Ameritas Investment Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Hold |
23,560
| – | – | 0.01% | 903 |
|
|
2025
Q1 | $467K | Hold |
23,560
| – | – | 0.02% | 843 |
|
|
2024
Q4 | $404K | Buy |
23,560
+746
| +3% | +$12.8K | 0.01% | 938 |
|
|
2024
Q3 | $456K | Buy |
22,814
+750
| +3% | +$15K | 0.01% | 879 |
|
|
2024
Q2 | $247K | Buy |
22,064
+1,135
| +5% | +$12.7K | 0.01% | 1131 |
|
|
2024
Q1 | $138K | Hold |
20,929
| – | – | ﹤0.01% | 1532 |
|
|
2023
Q4 | $94.6K | Hold |
20,929
| – | – | ﹤0.01% | 1770 |
|
|
2023
Q3 | $74.9K | Buy |
20,929
+4,115
| +24% | +$14.7K | ﹤0.01% | 1854 |
|
|
2023
Q2 | $62K | Hold |
16,814
| – | – | ﹤0.01% | 1909 |
|
|
2023
Q1 | $55.7K | Buy |
16,814
+2,876
| +21% | +$9.52K | ﹤0.01% | 1906 |
|
|
2022
Q4 | $47.4K | Hold |
13,938
| – | – | ﹤0.01% | 2087 |
|
|
2022
Q3 | $33K | Hold |
13,938
| – | – | ﹤0.01% | 2252 |
|
|
2022
Q2 | $27K | Buy |
+13,938
| New | +$27K | ﹤0.01% | 2375 |
|
|
2021
Q2 | – | Sell |
-4,185
| Closed | -$7K | – | 3046 |
|
|
2021
Q1 | $7K | Hold |
4,185
| – | – | ﹤0.01% | 2940 |
|
|
2020
Q4 | $8K | Hold |
4,185
| – | – | ﹤0.01% | 2869 |
|
|
2020
Q3 | $10K | Hold |
4,185
| – | – | ﹤0.01% | 2699 |
|
|
2020
Q2 | $12K | Hold |
4,185
| – | – | ﹤0.01% | 2610 |
|
|
2020
Q1 | $12K | Hold |
4,185
| – | – | ﹤0.01% | 2429 |
|
|
2019
Q4 | $17K | Hold |
4,185
| – | – | ﹤0.01% | 2476 |
|
|
2019
Q3 | $19K | Buy |
4,185
+2,543
| +155% | +$11.5K | ﹤0.01% | 2407 |
|
|
2019
Q2 | $6K | Hold |
1,642
| – | – | ﹤0.01% | 2908 |
|
|
2019
Q1 | $6K | Hold |
1,642
| – | – | ﹤0.01% | 2819 |
|
|
2018
Q4 | $4K | Hold |
1,642
| – | – | ﹤0.01% | 2878 |
|
|
2018
Q3 | $10K | Hold |
1,642
| – | – | ﹤0.01% | 2821 |
|
|
2018
Q2 | $7K | Buy |
+1,642
| New | +$7K | ﹤0.01% | 2896 |
|